HF
ARKG icon

HRT Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

HRT Financial’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,200
Closed -$322K – 4137
2026
Q1 		$322K Buy
+12,200
New +$357K ﹤0.01% 2820
2025
Q4 		– Sell
-8,800
Closed -$244K – 3148
2025
Q3 		$244K Buy
+8,800
New +$222K ﹤0.01% 2307

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HRT Financial's ARKG Position: Q2 2026 in Review

HRT Financial increased its ARK Genomic Revolution ETF (ARKG) stake by 637% in Q2 2026, buying an estimated $4.89M and bringing the position to 177,780 shares worth $7.48M. The position accounts for 0.01% of the portfolio, ranked #923.

HRT Financial first reported a position in ARKG in Q4 2020 and has held it in 13 quarters since. The position peaked at $33.5M in Q2 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • HRT Financial held 177,780 shares of ARK Genomic Revolution ETF worth $7.48M as of Q2 2026.
  • HRT Financial bought 153,646 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $4.89M.
  • ARK Genomic Revolution ETF made up 0.01% of HRT Financial's portfolio in Q2 2026, its #923 holding.
  • HRT Financial first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 13 quarters since.
  • HRT Financial's ARK Genomic Revolution ETF position peaked at $33.5M in Q2 2021.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.